Basics MaxCyte, Inc. Common Stock IPO Date: July 26, 2021 Sector: Healthcare Industry: Medical Devices Market Cap: $156.81M Activated in VL: True Average Daily Range Avg Daily Range: $0.16 | 3.04% Avg Daily Range (30 D): $0.05 | 3.46% Avg Daily Range (90 D): $0.06 | 3.52% Institutional Daily Volume Avg Daily Volume: .55M Avg Daily Volume (30 D): 1.04M Avg Daily Volume (90 D): .85M Trade Size Avg Trade Size (Sh.): 112 Avg Trade Size (Sh.) (30 D): 245 Avg Trade Size (Sh.) (90 D): 186 Institutional Trades Total Inst.Trades: 168 Avg Inst. Trade: $2.36M Avg Inst. Trade (30 D): $3.04M Avg Inst. Trade (90 D): $2.76M Avg Inst. Trade Volume: .4M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $4.16M Avg Closing Trade (30 D): $.7M Avg Closing Trade (90 D): $.7M Avg Closing Volume: 518.3K     News Jul 4, 2024 @ 1:11 PM Global Transfection Technologies Market Predicted ... Source: Polaris Market Research (Pmr) Jun 13, 2024 @ 1:55 PM Does MaxCyte (MXCT) Have the Potential to Rally 85... Source: Zacks Equity Research Jun 13, 2024 @ 12:50 PM Recent Price Trend in MaxCyte (MXCT) is Your Frien... Source: Zacks Equity Research May 29, 2024 @ 12:05 PM MaxCyte to Participate in William Blair 44th Annua... Source: MaxCyte, Inc May 22, 2024 @ 12:05 PM MaxCyte Signs Strategic Platform License Agreement... Source: MaxCyte, Inc Financials   TTM Q3 2025 Q2 2025 Basic EPS $-.43 $-.12 $-.12 Diluted EPS $-.43 $-.12 $-.12 Revenue $ 34.42M $ 6.83M $ 8.51M Gross Profit $ 27.53M $ 5.23M $ 6.99M Net Income / Loss $ -45.63M $ -12.42M $ -12.36M Operating Income / Loss $ -53.57M $ -14.15M $ -14.23M Cost of Revenue $ 6.89M $ 1.6M $ 1.52M Net Cash Flow $ -23.99M $ -2.25M $ -8.16M PE Ratio